A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in hospitalized adults with COVID-19 pneumonia. In addition, in a subgroup of patients who required high-flow oxygen, investigators found that interferon beta-1a was associated with more adverse events and worse outcomes.
from Top Health News -- ScienceDaily https://ift.tt/3G1lV36
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
Unraveling the power and influence of language
A choice was made to include each word in this sentence. Every message, even the most mundane, is crafted with a specific frame in mind that...
-
from Yahoo News - Latest News & Headlines https://ift.tt/m2VMCS1
-
from Yahoo News - Latest News & Headlines https://ift.tt/jYPuwNf
-
from Yahoo News - Latest News & Headlines https://ift.tt/Ot2Ebrh
No comments:
Post a Comment